University Of Vermont Medical Center

This study is testing if changing the timing of two common chemotherapy drugs (capecitabine and oxaliplatin) causes fewer and less severe side effects for people with gastrointestinal cancers. The goal is to see if this modified schedule is easier for patients to tolerate than th…

This study is testing whether a structured, long-term follow-up program helps people with inherited cancer syndromes stick to recommended cancer screening and prevention plans. It focuses on 200 adults with known genetic mutations, especially those living in rural areas, who will…